Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817388 · ClinicalTrials.gov registry record
Correlating Ic/Pbs Symptoms With Urine Biomarkers
A clinical trial, sponsored by Corewell Health East.
- Completed
- Registry status
- 26
- Enrollment target
NCT00817388: Completed study, sponsored by Corewell Health East.
NCT00817388 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00817388 has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-05 |
What the finished NCT00817388 record still lists
NCT00817388 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT00817388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00817388 about?
NCT00817388 is a clinical study titled "Correlating Ic/Pbs Symptoms With Urine Biomarkers". Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.
What is the current status of trial NCT00817388?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2009-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00817388?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT00817388?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia